Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism

Journal of Virology

Volumn 74, Issue 18, 2000, Pages 8635-8647

  Wu, P ^a   Xiao, W ^a   Conlon, T ^a   Hughes, J ^a   Agbandje Mckenna, M ^a   Ferkol, T ^a   Flotte, T ^a   Muzyczka, N ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; VIRUS DNA;

ADENO ASSOCIATED VIRUS; ARTICLE; DNA PACKAGING; GENE MAPPING; GENE THERAPY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SITE DIRECTED MUTAGENESIS; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS PARTICLE;

ALANINE; AMINO ACID SUBSTITUTION; CAPSID; CELL LINE; CHROMATOGRAPHY, AFFINITY; DEPENDOVIRUS; DNA MUTATIONAL ANALYSIS; DNA, VIRAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EPITOPES; GENETIC VECTORS; HELA CELLS; HUMANS; IMMUNOBLOTTING; MICROSCOPY, ELECTRON; MODELS, MOLECULAR; MUTAGENESIS, SITE-DIRECTED; PRECIPITIN TESTS; PROTEIN BINDING; RECEPTORS, VIRUS; TROPISM;

EID: 0033851104     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.18.8635-8647.2000     Document Type: Article

References (53)

1. The structure of human parvovirus B19 at 8 A resolution
2. Structure determination of feline panleukopenia virus empty particles
3. Functional implications of the structure of the murine parvovirus, minute virus of mice
4. Mutations adjacent to the dimple of the canine parvovirus capsid structure affect sialic acid binding
5. Adeno-associated viruses: An update
6. Adenovirus and adeno-associated virus as vectors for gene therapy
7. Herpes simplex virus types 1 and 2 completely help adenovirus-associated virus replication
8. Studies on the relationship between adeno-associated virus type 1 (AAV-1) and adenoviruses. II. Inhibition of adenovirus plaques by AAV; its nature and specificity
9. Structure, sequence, and function correlations among parvoviruses
10. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles
11. High resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis
12. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis
13. Integration of adeno-associated virus vectors in CD34+ human hematopoietic progenitor cells after transduction
14. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector
15. Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2
16. Characterization of recombinant adeno-associated virus-2 as a vehicle for gene delivery and expression into vascular cells
17. Characteristics of a human cell line transformed by DNA from human adenovirus type 5
18. Titration of AAV-2 particles via a novel capsid ELISA: Packaging of genomes can limit production of recombinant AAV-2
19. Genetics of adeno-associated virus: Isolation and preliminary characterization of adeno-associated virus type 2 mutants
20. Glycosaminoglycan-protein interactions: Definition of consensus sites in glycosaminoglycan binding proteins
21. Nuclear transport of the major capsid protein is essential for adeno-associated virus capsid formation
22. Improved methods for binding protein models in electron density maps and the location of errors in these models
23. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain
24. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors
25. Sequences required for coordinate induction of adeno-associated virus p19 and p40 promoters by Rep protein
26. Three-dimensional structure of Aleutian mink disease parvovirus: Implications for disease pathogenicity
27. Site-directed mutagenesis of adeno-associated virus type 2 structural protein initiation codons: Effects on regulation of synthesis and biological activity
28. Use of adeno-associated virus as a general transduction vector for mammalian cells
29. + hematopoietic progenitor cells: Donor variation and correlation of transgene expression with cellular differentiation
30. Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2
31. Adeno-associated virus expression systems for gene transfer
32. Insertional mutagenesis of AAV2 capsid and the production of recombinant virus
33. The canyon hypothesis. Hiding the host cell receptor attachment site on a viral surface from immune surveillance
34. Mutations in the carboxy terminus of adeno-associated virus 2 capsid proteins affect viral infectivity: Lack of an RGD integrin-binding motif
35. Assembly of viruslike particles by recombinant structural proteins of adeno-associated virus type 2 in insect cells
36. Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors
37. Nucleotide sequence and organization of the adeno-associated virus 2 genome
38. AlphaVbeta5 integrin: A co-receptor for adeno-associated virus type 2 infection
39. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions
40. Genetic analysis of adeno-associated virus: Properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function
41. Analysis of the cell and erythrocyte binding activities of the dimple and canyon regions of the canine parvovirus capsid
42. The three-dimensional structure of canine parvovirus and its functional implications
43. Structure determination of monoclinic canine parvovirus
44. The adeno-associated virus type 2 regulatory proteins Rep78 and Rep68 interact with the transcriptional coactivator PC4
45. Subcellular compartmentalization of adeno-associated virus type 2 assembly
46. Intermediates of adeno-associated virus type 2 assembly: Identification of soluble complexes containing Rep and Cap proteins
47. Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector
48. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus
49. Development of novel cell surface CD34-targeted recombinant adeno-associated virus vectors for gene therapy
50. Adeno-associated virus 2-mediated high efficiency gene transfer into immature and mature subsets of hematopoietic progenitor cells in human umbilical cord blood
51. In vitro packaging of adeno-associated virus DNA
52. Gene transfer into hepatoma cell lines via the serpin enzyme complex receptor
53. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield